
Stereochemistry and Pharmacologic Action based on Plane Isomerism, Optical Isomerism and Conformational Isomerism
- 1 Shanghai University
* Author to whom correspondence should be addressed.
Abstract
In a recent study, thalidomide has been proved to have positive pharmacological effects in the immune system, such as the treatment of lupus erythematosus and anti-tumor, but 60 years ago, because of its optical isomer, it led to many tragedies. This time, by collecting the data of papers, this paper mainly analyzes and summarizes the connection between stereochemistry and pharmacological action of drugs, and tried to find the main reasons for the isomers of different structures and their effects from the aspects of biology and medicine. 4-aminopyridine, 4-aminoquinoline, thalidomide, and macrolide compounds are mentioned in this article. It comes to the conclusion that the larger the plane structure area of some drugs, the better the efficacy; some drugs have therapeutic effects only in the R configuration and some drugs with different chiral structures have different pharmacological functions.
Keywords
Stereochemistry, drug activity, isomer, thalidomide
[1]. Brian J. (n.d.) Thompson Jean-Baptiste Biot. https://www.britannica.com/biography/Jean-Baptiste-Biot
[2]. cn.lamscience.com. (2025) Louis Pastur: Biographical inventions, experiments, and Facts. https://cn.lamscience.com/louis-pasteur-biography
[3]. P. E. Mason and J. W. Brady. "Tetrahedrality" and the Relationship between Collective Structure and Radial Distribution Functions in Liquid Water. J. Phys. Chem. B. 2007, 111 (20): 5669–5679.
[4]. Cushny A.R. (1926) Biological Relations of Optically Isomeric Substances, Balliere Tindall and Cos, London.
[5]. Hurwitz J., Furth J.J., Malamy M.H., Alexander M. (1962) The role of deoxyrbonucleic acid in ribonucleic acid synthesis, III. The inhibition of the enzymatic synthesis of ribonucleic acid and deoxyribonucleic acid by actinomycin D and proflavin, Proc natn Acad. Sci. U.S.A 48, 1222.
[6]. Jing Shi,Yu Feng. Advances in molecular biological mechanisms of bacterial RNA polymerase inhibitors [J]. Journal of Zhejiang University (Medical edition), 2019, 48 (01): 44-49.
[7]. Linlin Jiang, Mei Ye, Donglian Luo. Determination of Hachlorocyclohexane and dip-chlorophenyl trichloroethane residues in sediments by solid phase extraction and gas chromatography [J]. Journal of Shanghai Ocean University, 2012, 21(1):6. DOI:CNKI:SUN:SSDB.0.2012-01-011.
[8]. Weiguang Zhang, Shilin Zhang, Dong Guo, et al. Attention to chiral drugs: starting from the " thalidomide event" [J]. University Chemistry, 2019, 34 (09): 1-12.
[9]. Ru Chu. Stereochemistry and pharmacological action of drugs [J]. Journal of Zaozhuang Teachers College, 1991, (04): 69-74.
[10]. Xiaokang Lv. Stereoselective synthesis and pesticide activity of facial chiral compounds [D]. Guizhou University, 2024. DOI:10.27047/d.cnki.ggudu.2024.000033.
[11]. Ke Wan, Lixin Dai. Focusing on "chiral drugs" [J]. Research on scientific and technological terms, 2002, (02): 46-48.
[12]. Yipan Li, Longchan Liu, Linnan Li, et al. Chiral separation method and its application in the study of chiral components of traditional Chinese medicine [J]. Acta Pharmaceutica Sinica, 2023, 58 (06): 1566-1576. DOI:10.16438/j.0513-4870.2022-1198.
Cite this article
Ling,H. (2025). Stereochemistry and Pharmacologic Action based on Plane Isomerism, Optical Isomerism and Conformational Isomerism. Theoretical and Natural Science,98,45-51.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 3rd International Conference on Modern Medicine and Global Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).